Medication
NB-Rivaroxaban
DIN 02555107 · NB Pharma Inc. Likely a generic
What it is
- Active ingredients
- Rivaroxaban — 2.5 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2025-06-05
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Xarelto
- Reddy-Rivaroxaban
- Taro-Rivaroxaban
- PMS-Rivaroxaban
- Sandoz Rivaroxaban
- Riva Rivaroxaban
- Pro-Rivaroxaban
- Rivaroxaban
- Apo-Rivaroxaban
- Teva-Rivaroxaban
- Rivaroxaban
- Bio-Rivaroxaban
- M-Rivaroxaban
- Jamp Rivaroxaban
- AG-Rivaroxaban
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Blood and blood-forming organs
- ATC code
- B01AF01
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of B01AF01, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.